At a glance
ClinicalIndex Comparison RecordN/ACompleted· 44 enrolled
Drug / intervention
Active Provant Therapy System +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Multi-Center, Sham-Controlled, Double-Blind Randomized Withdrawal Study of PEMF Therapy to Evaluate Vibration Perception Threshold and Thermal Sensory in Subjects With Diabetic Peripheral Neuropathy in the Lower Extremity
In Brief
A clinical study evaluating Active Provant Therapy System and Inactive (sham) Provant Therapy System for Diabetic Peripheral Neuropathy. Completed, enrolled 44 participants across 1 site.
Detailed Summary
A study to demonstrate the effectiveness of PEMF treatment compared to sham treatment in changing Vibration Perception Threshold (VPT) and Thermal Sensory (QST) in patients with diabetic peripheral neuropathy (DPN) when treatment is administered twice daily through 120-day period.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetic Peripheral Neuropathy
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
Enrollment StartMar 2017
First PostedMar 2017
Primary CompletionDec 2017
TodayJul 2026
First PostedMar 13, 2017
Enrollment StartMar 9, 2017
Primary CompletionDec 26, 2017
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 9.3 years ago
Interventions
Active Provant Therapy Systemdevice
Treatment with active Provant Therapy System
Inactive (sham) Provant Therapy Systemdevice
Treatment with Inactive (sham) Provant Therapy System